切换导航
关闭
  • 菜单
  • Setting

Signaling Pathways - MST - Hck - 5-HT receptor - DPP-4

10 件产品

每页
清除全部
  1. XMU-MP-1
    A8735 XMU-MP-1
     2 Citation
    Target: MST
    Summary: MST1/2的强效选择性抑制剂
      ≥41.6 mg/mL
      insoluble in H2O
  2. Talabostat mesylate
    B3941 Talabostat mesylate
     2 Citation
    Target: DPP-4
    Summary: DPP4抑制剂
      ≥11.45 mg/mL
      ≥31 mg/mL
  3. Latrepirdine
    B1572 Latrepirdine
    Target: Voltage-gated Calcium Channels (CaV)|NMDA receptor|adrenergic receptor|Histamine receptors|GluR|5-HT receptor|dopamine receptors|AMPA receptor
    Summary: 脑细胞死亡抑制剂
      ≥19.62 mg/mL
      insoluble in H2O
  4. PP121
    B2172 PP121
    Target: mTOR|Eph Receptors|VEGFR|PDGFR|Bcr-Abl|Src|DNA-PK|P110|Hck
    Summary: 酪氨酸激酶和磷酸肌醇激酶双重抑制剂
      ≥15.95 mg/mL
      insoluble in H2O
  5. Saxagliptin
    A8650 Saxagliptin
    中文名: 沙格列汀
    Target: DPP-4
    Summary: DPP4抑制剂
      ≥14.85 mg/mL
      ≥8.32 mg/mL
  6. Teneligliptin hydrobromide
    A3865 Teneligliptin hydrobromide
    中文名: 氢溴酸替格列汀
    Target: DPP-4
    Summary: DDP4抑制剂
      ≥62.9 mg/mL
      ≥104.8 mg/mL
  7. Quetiapine
    A3744 Quetiapine
    中文名: 喹硫平
    Target: AChR|adrenergic receptor|5-HT receptor|Dopamine receptor|Histamine receptor
    Summary: 多巴胺受体拮抗剂
      ≥19.18 mg/mL
      insoluble in H2O
  8. TAK-901
    A4124 TAK-901
    Target: Aurora Kinases|FLT3|Src|JAK|LRRK2|Hck|FGR|YES|Fyn|ARG
    Summary: Aurora A/B抑制剂
      ≥25.25 mg/mL
      insoluble in H2O
  9. Alogliptin (SYR-322)
    A4038 Alogliptin (SYR-322)
     1 Citation
    中文名: 阿格列汀
    Target: DPP-4
    Summary: DPP-4抑制剂
      ≥14.75 mg/mL
      insoluble in H2O
  10. Sitagliptin phosphate monohydrate
    A4036 Sitagliptin phosphate monohydrate
     5 Citation
    中文名: 磷酸西他列汀一水合物
    Target: DPP-4
    Summary: DPP-4抑制剂
      ≥23.8 mg/mL
      ≥30.6 mg/mL

10 件产品

每页